Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk.
about
Current status and prospect of lung cancer gene therapyPolarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TANIL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cellsSunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy.Immunomodulation of cancer: potential use of selectively replicating agents.Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virusHypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors.Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancerTherapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gammaInhibition of tumor growth by elimination of granulocytes.Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinomaInterleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder.The curious incident of 3 melanomas and their possible origins-A case report and review of literature.Detection of immune suppressive neutrophils in peripheral blood samples of cancer patients.Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity.The polarization of immune cells in the tumour environment by TGFbeta.Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gammaInterferon gamma-independent rejection of interleukin 12-transduced carcinoma cells requires CD4+ T cells and Granulocyte/Macrophage colony-stimulating factorFMLP- and TNF-stimulated monoclonal Lym-1 antibody-dependent lysis of B lymphoblastoid tumour targets by neutrophils.Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically.
P2860
Q26825190-F3C0A001-B8F0-4AF7-9796-CC264AC20365Q29619346-C6575641-DD74-4452-BE0F-6C5D212D516BQ33670036-C41A23EB-AD6B-4C9D-90D7-3CD45A5DE9EFQ33848587-A0591E73-BA9A-4BB9-9806-29ECC663F19EQ33852789-019247DE-5948-4BC7-9C0C-FF4C498D1678Q33904276-5F3A144E-B4FC-49A4-BF25-C2CFA8BF4004Q34328867-C33C1335-B2F9-43E1-9317-3B0FF6C66CC5Q35774179-07E5679B-2290-4C0A-AB3E-66B7E4064F9CQ36136052-BBDDA40A-7A92-418B-9547-BB919B9F9983Q36136494-78245B47-4B63-4812-9DAE-F9A000C8B9BEQ36199032-5634A00A-9D87-4170-8B66-87254BC38E52Q36364220-956D63E8-D130-4B39-B4E5-6C6BE97767F3Q36615915-F60A61BC-03E7-434C-B2E5-2D50D0858675Q36618832-1FA28632-8A37-433F-8D12-178830972A12Q36866737-71E2EC87-1269-400E-973D-0E4877D6040EQ37127538-DE34272F-B3D0-40AE-BAA0-6A6755F6CE8CQ37357090-CD290A97-1D71-4828-9DF9-3561A020DEDBQ37454364-64F58B0E-5101-468C-98B5-23F74FF15333Q41546511-64229839-8EF9-450A-9B00-4F094685F7FDQ41886939-0A956D20-F3EB-46EC-BEE3-1EFB013A318EQ42033770-F0E7BC12-2B4F-42A9-83CB-E2C08C4436D1Q42389372-8A421673-DC72-40C0-9F83-4D353F652C41
P2860
Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Local cytokine availability el ...... ocyte-T-lymphocyte cross-talk.
@ast
Local cytokine availability el ...... ocyte-T-lymphocyte cross-talk.
@en
type
label
Local cytokine availability el ...... ocyte-T-lymphocyte cross-talk.
@ast
Local cytokine availability el ...... ocyte-T-lymphocyte cross-talk.
@en
prefLabel
Local cytokine availability el ...... ocyte-T-lymphocyte cross-talk.
@ast
Local cytokine availability el ...... ocyte-T-lymphocyte cross-talk.
@en
P2093
P1433
P1476
Local cytokine availability el ...... locyte-T-lymphocyte cross-talk
@en
P2093
P304
P407
P577
1992-09-01T00:00:00Z